European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale ...

Teva Pharmaceutical has announced a collaboration with Fosun Pharma to advance the global development of the ATTENUKINE ...

NextCure has entered a strategic partnership with Simcere Zaiming, to develop SIM0505, a new ADC targeting CDH6 for treating ...

Sweeping changes made by RFK Jr at the CDC have weakened the US's immunisation programme, according to former ACIP members.

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...

After Biogen failed with a takeover bid in January, Supernus has swooped in to buy the postpartum depression pill developer.

Surovatamig shows promise, but needs to outperform established therapies such as Blincyto and Aucatzyl.